CMS Imaging, Inc.
$44.5K 418 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation reported $44,745.31 across General Payments, Research, and Ownership to 40 physicians and teaching hospitals across 40 transactions.
- $44.7K Below-median payer
- All-tracks total
- 40 Below-median volume
- Transactions
- 40 Below-median reach
- Recipients
- −$53.3K
- General Payments vs PY2023
NeuroOne Medical Technologies Corporation reported $44,745.31 across all CMS Open Payments tracks (General + Research + Ownership) to 40 physicians and teaching hospitals in Program Year 2024 - ranking #1380 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $44,745.31, averaging $1.1K per recipient.
NeuroOne Medical Technologies Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer neuroone-medical-technologies-corporation NeuroOne Medical Technologies Corporation
$44.7K · #1380/1,925 · 0.0% industry · PY2024
- TOT $44.7K
- RANK #1380
- SHARE 0.0%
- TXN 40
- RCP 40
- CAT 2
- GEN $44.7K
- ΔGEN −$53.3K
- TOP1 33.4%
- PY 2024
Volume peers
Nearest volume peer: CMS Imaging, Inc. ($44.5K)
NeuroOne Medical Technologies Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
NeuroOne Medical Technologies Corporation's CMS-reported General Payments decreased by $53.3K (−54.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: NEUROONE MEDICAL TECHNOLOGIES CORPORATIONPY2023: NEUROONE MEDICAL TECHNOLOGIES CORPORATIONPY2024: NeuroOne Medical Technologies Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $98,041.83
- PY2024
- $44,745.31
What the Data Shows for NeuroOne Medical Technologies Corporation
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For NeuroOne Medical Technologies Corporation that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $41.3K across 21 transactions, 92.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 2 types of general payments, NeuroOne Medical Technologies Corporation's largest category was "Consulting Fee" at $41.3K - 92.2% of General Payments.
How NeuroOne Medical Technologies Corporation divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $41.3K | 21 | 92.2% |
| Food and Beverage | $3.5K | 19 | 7.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $38,596.91 (86.3%) of $44,745.31 in this company's General Payments records across 15 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for NeuroOne Medical Technologies Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Robert Gross
$14,939.82 across 4 reported transactions
- 2
Chengyuan Wu
$7,804.15 across 3 reported transactions
- 3
David Darrow
$5,993.97 across 6 reported transactions
- 4
Parag Patil
$5,358.97 across 11 reported transactions
- 5
Anthony Berg
$4,500.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
NeuroOne Medical Technologies Corporation ranks #1380 of 1,925 by total payments (bottom 28% by spend) but is notably more concentrated than that alone would suggest -- #766 of 1,838 by HHI (top 42% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Dentsply Ih Ab : $186.8K total payments, HHI 1956
- G21 Srl : $9.2K total payments, HHI 1918
- R-Pharm US LLC : $588.45 total payments, HHI 1917
- Dmg America LLC : $176.1K total payments, HHI 1902
- United Imaging Healthcare North America, Inc. : $270.2K total payments, HHI 1892
- ulrich medical USA, Inc. : $199.2K total payments, HHI 1891
- NeuroOne Medical Technologies Corporation (this company) : $44.7K total payments, HHI 1889
- Eminent Spine, LLC : $35.3K total payments, HHI 1889
- SiVantage, Inc. : $3.8K total payments, HHI 1887
- Air Techniques, Inc. : $23.7K total payments, HHI 1886
- OnMark, Inc. : $93.7K total payments, HHI 1884
- Sechrist Industries Inc : $740.50 total payments, HHI 1882
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as NeuroOne Medical Technologies Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about NeuroOne Medical Technologies Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with NeuroOne Medical Technologies Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
OptumHealth Care Solutions, LLC
$44.5K 2,039 recipients
Compare payment profiles
Zyla Life Sciences, Inc.
$45.0K 0 recipients
Compare payment profiles
Whitehall International Inc
$44.4K 13 recipients
Compare payment profiles
AccuTec Blades Inc
$45.1K 9 recipients
Compare payment profiles
Hollister Incorporated
$45.3K 370 recipients
Compare payment profiles
Put this to use
NeuroOne Medical Technologies Corporation ranks #1380 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just NeuroOne Medical Technologies Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.